INS and metastatic malignant neoplasm in the lymph nodes: In agreement with our clinical observations is the ability of heparanase to augment insulin-induced proliferation in breast carcinoma cells in vitro (Figure 3D), particularly relevant in light of the previous reports showing association between high proliferative rate of breast carcinoma cells and lymph node metastasis [33, 34].